Aligos Therapeutics

$0.00 (0.00%) As of 5:00 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALGS and other ETFs, options, and stocks.

About ALGS

Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is engaged in in developing therapeutics for chronic liver diseases and viral infections. The firm is focused on the discovery and development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses, as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH).

CEO
Lawrence M. Blatt
Employees
93
Headquarters
South San Francisco, California
Founded
2018

ALGS Key Statistics

Market cap
47.13M
Price-Earnings ratio
—
Dividend yield
—
Average volume
516.69K
High today
$1.24
Low today
$1.18
Open price
$1.20
Volume
54.64K
52 Week high
$34.31
52 Week low
$1.03

ALGS Earnings

-$11.00
-$7.33
-$3.67
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure